ClinVar Miner

Submissions for variant NM_003119.4(SPG7):c.4G>A (p.Ala2Thr)

gnomAD frequency: 0.00136  dbSNP: rs535030441
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 8
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV001722098 SCV000252311 likely benign not provided 2020-09-01 criteria provided, single submitter clinical testing This variant is associated with the following publications: (PMID: 16534102, 20301286)
Athena Diagnostics Inc RCV001722098 SCV000615439 uncertain significance not provided 2023-02-27 criteria provided, single submitter clinical testing Available data are insufficient to determine the clinical significance of the variant at this time. The frequency of this variant in the general population is uninformative in assessment of its pathogenicity (http://gnomad.broadinstitute.org). Computational tools predict that this variant is not damaging. The variant is located in a region that is considered important for protein function and/or structure.
Invitae RCV000817246 SCV000957796 likely benign Hereditary spastic paraplegia 7 2024-01-18 criteria provided, single submitter clinical testing
Illumina Laboratory Services, Illumina RCV000817246 SCV001276264 uncertain significance Hereditary spastic paraplegia 7 2017-04-27 criteria provided, single submitter clinical testing This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance.
CeGaT Center for Human Genetics Tuebingen RCV001722098 SCV002063548 uncertain significance not provided 2021-11-01 criteria provided, single submitter clinical testing
Genome Diagnostics Laboratory, The Hospital for Sick Children RCV001847886 SCV002105889 uncertain significance Hereditary spastic paraplegia 2019-01-01 criteria provided, single submitter clinical testing
Mayo Clinic Laboratories, Mayo Clinic RCV001722098 SCV002541375 uncertain significance not provided 2021-05-12 criteria provided, single submitter clinical testing
Ambry Genetics RCV002515437 SCV003598328 likely benign Inborn genetic diseases 2022-01-31 criteria provided, single submitter clinical testing This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.